IL18 and COVID-19: In addition, enhanced plasma levels of pyroptosis markers were detected in COVID-19 patients, and the levels of caspase -1 and IL-18 in serum correlated with the degree of COVID-19 severity (12, 22, 29, 220, 221), particularly in elderly patients (234).